SlideShare une entreprise Scribd logo
1  sur  4
Télécharger pour lire hors ligne
Neural Tube Defects

Objective :
   •   Definition
   •   Types
   •   Causes
   •   Detection
   •   Prevention
   •   Treatment

Embryology
   •   The spinal cord begin developing in the third week of pregnancy from a flat piece of tissue called the
       "neural plate".
   •   The neural tube start as the neural plate ,which develops a groove in the middle called neural
       groove.
   •   It gradually deepens until it is completely separated from the surface ,that is the ectoderm.
   •   Anterior neuropore closure – 25th day
   •   Posterior neuropore closure – 27th day
   •   This process is completed by the 28 th day of gestation

Definition
   •   Neural tube defects (NTDs) are serious birth defects with symptoms that range from mild to severe
       impairment. They are caused by incomplete development of the brain, spinal cord and/or their
       protective coverings.
   •   This neural tube fusing process usually is complete by 28 days of gestation.
   •   Error in this fusing will result in a neural tube defect

Epidemiology
   •   NTDs are among the most common birth defects.
   •   They exhibit a marked geographical variation, with the incidence higher in Great Britain and lower
       in Japan.
   •   In white populations, the lowest birth incidence was noted in mainland Europe and the highest in
       Great Britain (especially Ireland).
   •   Currently, the highest reported incidence is in Northern China (3.7 cases per 1000 live births).
   •   Indian and Eastern Mediterranean populations (with the exception of Israeli Jews) also have
       relatively high incidences of NTDs. However, unlike the Western white populations, anencephaly is
       more common than spina bifida.

Risk factors
   • Pregnant women who are taking medication for epilepsy.
   • women with folic acid deficiencies
   • Race/geographical location:
       certain Hispanic subpopulations, and among population groups in Ireland, China, and the United
Kingdom.
   • Maternal insulin-dependent diabetes mellitus
   • Maternal weight ,age
   • Maternal hyperthermia (i.e., exposure to high temperatures early in pregnancy, such as hot tub use or
       high fever)
•   Previous NTD-affected pregnancy




Types of NTD

   •   Anencephaly
   •   Encephalocele
   •   Hydranencephaly
   •   Iniencephaly
   •   Spina Bifida
           – Spina Bifida Manifesta
           – Spina Bifida Occulta

1- Anencephaly
    • Means “without head”, foetus will be in an acranial state
    • Results from a neural tube defect that occurs when the cephalic (head) end of the neural tube fails to
       close resulting in the absence of a major portion of the brain, skull, and scalp
    • Foetus will not gain consciousness due to the loss of the cerebrum that controls cognitive activities
       and will be incompatible with life

2- Encephalocele

   •   It is a neural tube defect characterized by sac-like protrusions of the brain and the membranes that
       cover it through openings in the skull.
   •   Usually occipital, also called high spina bifida
   •   Sometimes, associated with other conditions like multicystic kidneys or polydactyl

3- Hydranencephaly
    • This occurs when the cerebral hemispheres are absent and replaced by sacs filled with cerebrospinal
       fluid.
    • An infant with hydranencephaly may appear normal at birth or may have some distortion of the skull
       and upper facial features due to fluid pressure inside the skull.
    • People will hydranencephaly will suffer from visual impairment, lack of growth, deafness, blindness,
       paralysis, and intellectual deficits.
4- Iniencephaly

     •    Combines extreme retroflexion (backward bending) of the head with severe defects of the spine.
     •    The neck is usually absent
     •    Incompatible with life due to deformity of the body

5- Spina bifida
    • Failure of the laminae of the vertebrae to fuse together (the vertebral arches are absent)
    • Usually occurs in the lumbosacral region
    • Has two types:
    a) Spina bifida occulta
    b) Spina bifida manifesta

a) Spina bifida occulta


b) Spina bifida manifesta
    • Manifesta means “open or shown”
    • Consists of two main appearances:
- Meningocele: cerebrospinal fluid only
- Meningomyelocele: cerebrospinal fluid and nerve tissue

Element Meningocele                                         Meningomyelocele
Definition Fluid-filled sac with meninges involved but      Meninges and spinal tissue protruding through a
           neural tissue unaffected (cele means sac)        dorsal defect in the vertebrae

Prognosis      Least common form and least hazardous        Most grave form

Types          Dermal sinus                                 Meningocele
               Lipoma of the cord                           Meningomyelocele
               Diastematomyelioma
               Thickened Filum Terminal
               Thetered cord



Investigation
 •       Blood test
 •       Ultrasound
 •       Amniocentesis

Blood test :
 o Measures the level of maternal serum alpha fetoprotein (MSAFP)
 o Alpha-fetoprotein (AFP) is made naturally by the fetus and placenta.
 o But if abnormally high levels of this protein appear in the mother’s bloodstream it may indicate that
     the fetus has a NTD.
 o It is not a diagnostic tool, only serve as screening test.
Ultrasound :
 o Reliable tests for neural tube defect
 o Can be done in second trimester cause that’s when usually most of the symptoms of NTD exhibit
             themselves

Amniocentesis
 o Indicates the level of amniotic fluid α-fetoprotein(AFAFP)
 o Normally, small amount of AFAFP is found.
 o When an open NTD is present, the amniotic fluid contains an elevated amount of AFP because the
    skin surrounding the baby's spine is gone and AFP leaks into the amniotic sac.


Prevention
   • There is no single cause of NTD nor any known way to prevent it entirely.
   • However, dietary supplementation with folic acid has been shown to be helpful in reducing the risk
       of NTDs

Folic Acid
    • Sources: dark green vegetables, egg yolks, and some fruits.
    • Dosage: 0.4 mg/day (at least 3 months before conception &for the first 12 weeks of pregnancy)
    • Women who have already had a baby with a NTD, or are taking anticonvulsant medication should
       take a higher dose of 4–5 mg/day

Treatment
      Medical care
 The newborn with an open NTD should be kept warm and the defect covered with a sterile wet saline
dressing. The patient should be positioned in the prone position to prevent pressure on the defect.

        Surgical Care
     o   The newborn with an open NTD should undergo prompt closure of the defect. The closure involves
         classic neurosurgical techniques.
     o   Children with hydrocephalus also should have a ventriculoperitoneal shunt placed at the time of
         myelomeningocele closure.
     o   Patients presenting with symptomatic Chiari malformations should undergo suboccipital craniotomy
         and decompression of the posterior fossa and tonsils.
     o   Children with syrinx need a laminectomy and placement of a syringosubarachnoid stent to divert the
         CSF out of the central canal.



Done by Group 2

Contenu connexe

Plus de Anan

Local Anesthetics
Local AnestheticsLocal Anesthetics
Local AnestheticsAnan
 
Pain
PainPain
PainAnan
 
Pain1
Pain1Pain1
Pain1Anan
 
Pain1
Pain1Pain1
Pain1Anan
 
Vertebral Column Lecture
Vertebral Column LectureVertebral Column Lecture
Vertebral Column LectureAnan
 
External Skull (Practical)
External Skull (Practical)External Skull (Practical)
External Skull (Practical)Anan
 
Embryology Of Neural Tube (Lecture)
Embryology Of Neural Tube (Lecture)Embryology Of Neural Tube (Lecture)
Embryology Of Neural Tube (Lecture)Anan
 
Vertebral Canal Lecture Notes
Vertebral Canal Lecture NotesVertebral Canal Lecture Notes
Vertebral Canal Lecture NotesAnan
 
Ntd Group 12
Ntd Group 12Ntd Group 12
Ntd Group 12Anan
 
Group 12 Docu
Group 12 DocuGroup 12 Docu
Group 12 DocuAnan
 
Development Of Vertebral Column
Development Of Vertebral ColumnDevelopment Of Vertebral Column
Development Of Vertebral ColumnAnan
 
Development Of Vertebral Column Group 11
Development Of Vertebral Column Group 11Development Of Vertebral Column Group 11
Development Of Vertebral Column Group 11Anan
 
Development Of Vertebral Column Group 1
Development Of Vertebral Column Group 1Development Of Vertebral Column Group 1
Development Of Vertebral Column Group 1Anan
 
Dr Shaker Ee
Dr Shaker EeDr Shaker Ee
Dr Shaker EeAnan
 
Clinical Features Of Neural Tube Defects
Clinical Features Of Neural Tube DefectsClinical Features Of Neural Tube Defects
Clinical Features Of Neural Tube DefectsAnan
 
Spinal Dysraphism[1]
Spinal  Dysraphism[1]Spinal  Dysraphism[1]
Spinal Dysraphism[1]Anan
 

Plus de Anan (20)

Local Anesthetics
Local AnestheticsLocal Anesthetics
Local Anesthetics
 
Pain
PainPain
Pain
 
Pain1
Pain1Pain1
Pain1
 
Pain1
Pain1Pain1
Pain1
 
Vertebral Column Lecture
Vertebral Column LectureVertebral Column Lecture
Vertebral Column Lecture
 
External Skull (Practical)
External Skull (Practical)External Skull (Practical)
External Skull (Practical)
 
Embryology Of Neural Tube (Lecture)
Embryology Of Neural Tube (Lecture)Embryology Of Neural Tube (Lecture)
Embryology Of Neural Tube (Lecture)
 
Vertebral Canal Lecture Notes
Vertebral Canal Lecture NotesVertebral Canal Lecture Notes
Vertebral Canal Lecture Notes
 
Ntd
NtdNtd
Ntd
 
Ee
EeEe
Ee
 
E E
E EE E
E E
 
Ntd Group 12
Ntd Group 12Ntd Group 12
Ntd Group 12
 
Group 12 Docu
Group 12 DocuGroup 12 Docu
Group 12 Docu
 
Development Of Vertebral Column
Development Of Vertebral ColumnDevelopment Of Vertebral Column
Development Of Vertebral Column
 
Development Of Vertebral Column Group 11
Development Of Vertebral Column Group 11Development Of Vertebral Column Group 11
Development Of Vertebral Column Group 11
 
Development Of Vertebral Column Group 1
Development Of Vertebral Column Group 1Development Of Vertebral Column Group 1
Development Of Vertebral Column Group 1
 
Ee
EeEe
Ee
 
Dr Shaker Ee
Dr Shaker EeDr Shaker Ee
Dr Shaker Ee
 
Clinical Features Of Neural Tube Defects
Clinical Features Of Neural Tube DefectsClinical Features Of Neural Tube Defects
Clinical Features Of Neural Tube Defects
 
Spinal Dysraphism[1]
Spinal  Dysraphism[1]Spinal  Dysraphism[1]
Spinal Dysraphism[1]
 

Dernier

SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 

Dernier (20)

SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 

Ntd Group 2

  • 1. Neural Tube Defects Objective : • Definition • Types • Causes • Detection • Prevention • Treatment Embryology • The spinal cord begin developing in the third week of pregnancy from a flat piece of tissue called the "neural plate". • The neural tube start as the neural plate ,which develops a groove in the middle called neural groove. • It gradually deepens until it is completely separated from the surface ,that is the ectoderm. • Anterior neuropore closure – 25th day • Posterior neuropore closure – 27th day • This process is completed by the 28 th day of gestation Definition • Neural tube defects (NTDs) are serious birth defects with symptoms that range from mild to severe impairment. They are caused by incomplete development of the brain, spinal cord and/or their protective coverings. • This neural tube fusing process usually is complete by 28 days of gestation. • Error in this fusing will result in a neural tube defect Epidemiology • NTDs are among the most common birth defects. • They exhibit a marked geographical variation, with the incidence higher in Great Britain and lower in Japan. • In white populations, the lowest birth incidence was noted in mainland Europe and the highest in Great Britain (especially Ireland). • Currently, the highest reported incidence is in Northern China (3.7 cases per 1000 live births). • Indian and Eastern Mediterranean populations (with the exception of Israeli Jews) also have relatively high incidences of NTDs. However, unlike the Western white populations, anencephaly is more common than spina bifida. Risk factors • Pregnant women who are taking medication for epilepsy. • women with folic acid deficiencies • Race/geographical location: certain Hispanic subpopulations, and among population groups in Ireland, China, and the United Kingdom. • Maternal insulin-dependent diabetes mellitus • Maternal weight ,age • Maternal hyperthermia (i.e., exposure to high temperatures early in pregnancy, such as hot tub use or high fever)
  • 2. Previous NTD-affected pregnancy Types of NTD • Anencephaly • Encephalocele • Hydranencephaly • Iniencephaly • Spina Bifida – Spina Bifida Manifesta – Spina Bifida Occulta 1- Anencephaly • Means “without head”, foetus will be in an acranial state • Results from a neural tube defect that occurs when the cephalic (head) end of the neural tube fails to close resulting in the absence of a major portion of the brain, skull, and scalp • Foetus will not gain consciousness due to the loss of the cerebrum that controls cognitive activities and will be incompatible with life 2- Encephalocele • It is a neural tube defect characterized by sac-like protrusions of the brain and the membranes that cover it through openings in the skull. • Usually occipital, also called high spina bifida • Sometimes, associated with other conditions like multicystic kidneys or polydactyl 3- Hydranencephaly • This occurs when the cerebral hemispheres are absent and replaced by sacs filled with cerebrospinal fluid. • An infant with hydranencephaly may appear normal at birth or may have some distortion of the skull and upper facial features due to fluid pressure inside the skull. • People will hydranencephaly will suffer from visual impairment, lack of growth, deafness, blindness, paralysis, and intellectual deficits.
  • 3. 4- Iniencephaly • Combines extreme retroflexion (backward bending) of the head with severe defects of the spine. • The neck is usually absent • Incompatible with life due to deformity of the body 5- Spina bifida • Failure of the laminae of the vertebrae to fuse together (the vertebral arches are absent) • Usually occurs in the lumbosacral region • Has two types: a) Spina bifida occulta b) Spina bifida manifesta a) Spina bifida occulta b) Spina bifida manifesta • Manifesta means “open or shown” • Consists of two main appearances: - Meningocele: cerebrospinal fluid only - Meningomyelocele: cerebrospinal fluid and nerve tissue Element Meningocele Meningomyelocele Definition Fluid-filled sac with meninges involved but Meninges and spinal tissue protruding through a neural tissue unaffected (cele means sac) dorsal defect in the vertebrae Prognosis Least common form and least hazardous Most grave form Types Dermal sinus Meningocele Lipoma of the cord Meningomyelocele Diastematomyelioma Thickened Filum Terminal Thetered cord Investigation • Blood test • Ultrasound • Amniocentesis Blood test : o Measures the level of maternal serum alpha fetoprotein (MSAFP) o Alpha-fetoprotein (AFP) is made naturally by the fetus and placenta. o But if abnormally high levels of this protein appear in the mother’s bloodstream it may indicate that the fetus has a NTD. o It is not a diagnostic tool, only serve as screening test.
  • 4. Ultrasound : o Reliable tests for neural tube defect o Can be done in second trimester cause that’s when usually most of the symptoms of NTD exhibit themselves Amniocentesis o Indicates the level of amniotic fluid α-fetoprotein(AFAFP) o Normally, small amount of AFAFP is found. o When an open NTD is present, the amniotic fluid contains an elevated amount of AFP because the skin surrounding the baby's spine is gone and AFP leaks into the amniotic sac. Prevention • There is no single cause of NTD nor any known way to prevent it entirely. • However, dietary supplementation with folic acid has been shown to be helpful in reducing the risk of NTDs Folic Acid • Sources: dark green vegetables, egg yolks, and some fruits. • Dosage: 0.4 mg/day (at least 3 months before conception &for the first 12 weeks of pregnancy) • Women who have already had a baby with a NTD, or are taking anticonvulsant medication should take a higher dose of 4–5 mg/day Treatment  Medical care The newborn with an open NTD should be kept warm and the defect covered with a sterile wet saline dressing. The patient should be positioned in the prone position to prevent pressure on the defect.  Surgical Care o The newborn with an open NTD should undergo prompt closure of the defect. The closure involves classic neurosurgical techniques. o Children with hydrocephalus also should have a ventriculoperitoneal shunt placed at the time of myelomeningocele closure. o Patients presenting with symptomatic Chiari malformations should undergo suboccipital craniotomy and decompression of the posterior fossa and tonsils. o Children with syrinx need a laminectomy and placement of a syringosubarachnoid stent to divert the CSF out of the central canal. Done by Group 2